Overview

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy an safety of eltrombopag to treat chemotherapy-induced thrombocytopenia
Phase:
Phase 2
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital